 |
 |
BIOTHERAPEUTICS |
| |
USV has been successful in developing therapeutic proteins and peptides by recombinant* and chemical synthesis processes. These include hGH, Enterokinase, hG-CSF, Teriparatide and PDGF-BB which have been developed using recombinant DNA (rDNA) technology and Eptifibatide and Bivalirudin, by chemical synthesis.
| Product |
Status |
| Eptifibatide |
Commercialized |
| Enterokinase |
Commercialized |
| Bivalirudin |
Commercialized |
| rhGH |
Clinicals |
| PDGF-BB |
Clinicals |
| Teriparatide |
Clinicals |
| rhG-CSF |
Pre-clinicals |
| PEG-GCSF |
Pre-clinicals |
| PEG-IFN |
Scale-up |
|
| |
* We are open to third party product development using our expression platforms. Contact us for details.
Disclaimer: Products under patents are offered for sale only in those countries where patents have expired.
|
|
|
|
|
